Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica

Multiple Sclerosis

Volumn 22, Issue 10, 2016, Pages 1337-1348

  Yamasaki, Ryo ^a   Matsushita, Takuya ^a   Fukazawa, Toshiyuki ^b   Yokoyama, Kazumasa ^c   Fujihara, Kazuo ^d   Ogino, Mieko ^e   Yokota, Takanori ^f   Miyamoto, Katsuichi ^g   Niino, Masaaki ^h   Nomura, Kyoichi ⁱ   Tomioka, Ryo ^j   Tanaka, Masami ^k   Kawachi, Izumi ^l   Ohashi, Takashi ^m   Kaida, Ken Ichi ⁿ   Matsui, Makoto ^o   Nakatsuji, Yuji ^p   Ochi, Hirofumi ^q   Fukaura, Hikoaki ^r   Kanda, Takashi ^s   Nagaishi, Akiko ^t   Togo, Kanae ^u   Mizusawa, Hidehiro ^f   Murai, Hiroyuki ^a   Kira, Jun Ichi ^a   more..

^a KYUSHU UNIVERSITY   (Japan)

^b Sapporo Neurology Clinic   (Japan)

^c JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h HOKKAIDO MEDICAL CENTER   (Japan)

ⁱ SAITAMA MEDICAL UNIVERSITY   (Japan)

^j SAITAMA MEDICAL UNIVERSITY   (Japan)

^k UTANO NATIONAL HOSPITAL   (Japan)

^l NIIGATA UNIVERSITY   (Japan)

^m TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

ⁿ NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^o KANAZAWA MEDICAL UNIVERSITY   (Japan)

^p OSAKA UNIVERSITY   (Japan)

^q EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^r IWATE MEDICAL UNIVERSITY   (Japan)

^s YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^t Nagasaki Kawatana Medical Center   (Japan)

^u PFIZER INC   (United States)

more..

Author keywords

corticosteroids; methylprednisolone; Multiple sclerosis; neuromyelitis optica; pulse therapy

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; AZATHIOPRINE; GLUCOCORTICOID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMORBIDITY; DISEASE DURATION; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG RESPONSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMMUNOTHERAPY; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PLASMAPHERESIS; RELAPSE; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; VERY ELDERLY; AGE DISTRIBUTION; MULTIPLE CYCLE TREATMENT; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84986626313     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515617248     Document Type: Article

References (18)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
2. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-477.
3. Sloka JS, Stefanelli M,. The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler 2005; 11: 425-432.
4. Milligan NM, Newcombe R, Compston DA,. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry 1987; 50: 511-516.
5. Thompson AJ, Kennard C, Swash M, et al. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology 1989; 39: 969-971.
6. Brusaferri F, Candelise L,. Steroids for multiple sclerosis and optic neuritis: A meta-analysis of randomized controlled clinical trials. J Neurol 2000; 247: 435-442.
7. Miller DM, Weinstock-Guttman B, Bethoux F, et al. A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler 2000; 6: 267-273.
8. Kira J,. Multiple sclerosis in the Japanese population. Lancet Neurol 2003; 2: 117-127.
9. Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010; 17: 1019-1032.
10. Kira J, Yamasaki R, Yoshimura S, et al. Efficacy of methylprednisolone pulse therapy for acute relapse in Japanese patients with multiple sclerosis and neuromyelitis optica: A multicenter retrospective analysis: 1. Whole group analysis. Clin Exp Neuroimmunol 2013; 4: 305-317.
11. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005; 58: 840-846.
12. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
13. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
14. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006; 77: 1073-1075.
15. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007; 130: 1206-1223.
16. Kira J,. Genetic and environmental factors underlying the rapid changes in epidemiological and clinical features of multiple sclerosis and neuromyelitis optica in Japanese. Clin Exp Neuroimmunol 2013; 4: 261-273.
17. Abboud H, Petrak A, Mealy M, et al. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler 2016; 22: 185-192.
18. Bonnan M, Valentino R, Olindo S, et al. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler 2009; 15: 487-492.